Please assess the completion status of the following clinical trial:

Trial Title: Spitex-SpiTal-Autonomie-Reha-Kraft

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Community-dwelling prior to the hip fracture event~* Living alone or with a partner/family member~* Living in the city of Zurich~* age 70+~* Acute hip or pelvis fracture after minimal trauma (resulting from a fall occurring from a standard height and without the involvement of others or a vehicle)~* Living at home without or with minimal (i.e. no more than 1x/day) support from the Spitex (ambulant nursing service) before the hip fracture~* Participant is mentally competent (judicious) based on the treating physicians' opinion at the screening visit.~* Inpatient rehabilitation or inpatient transitional care at a nursing home or ambulatory standard of care~* The participant understands the study procedures and voluntarily agree to participate in the study and comply with all its procedures by giving written informed consent~Exclusion Criteria:~* Patients who are expected to return home without help (i.e. no more care than Spitex 1x/day or physiotherapy 2x/week needed) directly after acute care are excluded.~* Conservative treatment of acute hip fracture or surgical treatment that does not allow full weight bearing after surgery~* Currently under cancer treatment or has active cancer (except for non-melanoma skin cancer)~* Major visual or hearing impairment (visual and/or hearing aids are allowed) or other serious illness that would preclude participation~* 24-hour nursing care need as this cannot be offered within the STARK package~* Mobility impairment that precludes return to own apartment~* Planned nursing home admission after acute hospital stay~* Current participation in another clinical trial, or plans of such participation in the next 12 months (corresponding to the study duration)~* Inability to read and/or speak German to an extent necessary to understand instructions and participate in the study~* Unwilling to forego any additional vitamin D supplementation (bolus or regular intake).

- Gender: ALL
- Minimum Age: 70 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- STARK intervention (Type: ACTIVE_COMPARATOR): New care concept for hip fracture patients
- Standard Care (Type: OTHER): Swiss standard of care for hip fracture patients

Based on this trial design, predict the completion outcome and termination type (if applicable).